To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT07619833 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07619833
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-11-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.